enVVeno Medical (NVNO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on enVVeno Medical (NVNO) is Moderate Underperform.

The composite score behind that read is -0.36, weighing +0.10 of bullish evidence against -0.41 bearish.

enVVeno Medical last closed at $8.01, -1.11% on the session.

Against the IVW growth benchmark the position is -2.03% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

16 graded predictions for NVNO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks enVVeno Medical in the 16th percentile on return on equity, where 100 is best.

enVVeno Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $5.53M.

StockMap tracks enVVeno Medical as the 131st largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite enVVeno Medical ranks 115th of 133 in the group, against a group median of -0.21.